Can cancer treatment also kick the habit? new study tests combined approach
NCT ID NCT02540174
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether adding a structured addiction treatment program to standard cancer care helps patients with head and neck or lung cancer quit smoking and reduce alcohol use. 133 patients were randomly assigned to either the integrated program or usual care. The main goal was to see how many patients were tobacco-free at 12 months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
integrated addiction treatment program
What this could lead to
If it works, this could show that combining addiction treatment with cancer care helps more patients quit smoking and drinking, potentially improving their overall health and cancer outcomes.
What could go wrong
This is a completed study with 133 participants, so results are available but may not apply to all patients. The program is intensive and may not be feasible in all hospitals.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHRU of Lille : Albert Calmette Hospital
Lille, 59037, France
-
CHRU of Lille: Huriez Hospital
Lille, 59037, France
-
Oscar Lambret Center
Lille, 59020, France